These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18217249)

  • 1. Disease-modifying drugs for Alzheimer's: hope or hype? New Alzheimer's drugs are now in clinical trials. Experts advise cautious optimism.
    Harv Ment Health Lett; 2007 Oct; 24(4):1-3. PubMed ID: 18217249
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease modifying drugs targeting β-amyloid.
    Ozudogru SN; Lippa CF
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):296-300. PubMed ID: 22815077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New approaches for the development of anti-Alzheimer's disease drugs based on the cholinergic hypothesis and amyloid hypothesis].
    Sugimoto H
    Nihon Yakurigaku Zasshi; 2008 May; 131(5):338-40. PubMed ID: 18480562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of Alzheimer's disease: current status and future development].
    Schmidt R; Neff F; Lampl C; Benke T; Anditsch M; Bancher C; Dal-Bianco P; Reisecker F; Marksteiner J; Rainer M; Kapeller P; Dodel R
    Neuropsychiatr; 2008; 22(3):153-71. PubMed ID: 18826870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in developing anti-Alzheimer drugs].
    Tabira T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):34P-36P. PubMed ID: 12491773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease: New therapeutic strategies].
    Villegas S
    Med Clin (Barc); 2015 Jul; 145(2):76-83. PubMed ID: 25245784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.
    Oehlrich D; Berthelot DJ; Gijsen HJ
    J Med Chem; 2011 Feb; 54(3):669-98. PubMed ID: 21141968
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
    Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
    J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New set of Alzheimer's trials focus on prevention.
    Corbyn Z
    Lancet; 2013 Feb; 381(9867):614-5. PubMed ID: 23444487
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alzheimer's disease: therapeutic perspectives].
    Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
    Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
    Zhang M; Hausmann L; Song W
    J Neurochem; 2013 May; 125(3):329-31. PubMed ID: 23405973
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing Alzheimer's Disease Treatment: Lessons from CTAD 2018.
    Vellas B; Bain LJ; Touchon J; Aisen PS
    J Prev Alzheimers Dis; 2019; 6(3):198-203. PubMed ID: 31062835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective BACE1 inhibitor VIa reduces amyloid-β production in cell and mouse models of Alzheimer's disease.
    Cheng X; Zhou Y; Gu W; Wu J; Nie A; Cheng J; Zhou J; Zhou W; Zhang Y
    J Alzheimers Dis; 2013; 37(4):823-34. PubMed ID: 23948917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elucidation of mechanism underlying amyloid-beta peptide aggregation and its neurotoxicity expression and inhibition of these molecular processes by beneficial synthetic and natural compounds with low-molecular weights-new approaches to fundamental treatment and prevention of Alzheimer's disease].
    Yamakuni T
    Yakugaku Zasshi; 2010 Apr; 130(4):493-4. PubMed ID: 20371991
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic research for Alzheimer's disease drugs].
    Yamanishi Y; Ueno M; Ogura H
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):489-93. PubMed ID: 18079600
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
    Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
    Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 100 years and counting: prospects for defeating Alzheimer's disease.
    Roberson ED; Mucke L
    Science; 2006 Nov; 314(5800):781-4. PubMed ID: 17082448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.